Biofrontera (BFRI) Competitors $0.98 -0.04 (-3.92%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends BFRI vs. SRZN, VRCA, IXHL, RAPT, RNXT, PMN, LIAN, NXTC, DRRX, and KALAShould you be buying Biofrontera stock or one of its competitors? The main competitors of Biofrontera include Surrozen (SRZN), Verrica Pharmaceuticals (VRCA), Incannex Healthcare (IXHL), RAPT Therapeutics (RAPT), RenovoRx (RNXT), ProMIS Neurosciences (PMN), LianBio (LIAN), NextCure (NXTC), DURECT (DRRX), and KALA BIO (KALA). These companies are all part of the "pharmaceutical products" industry. Biofrontera vs. Surrozen Verrica Pharmaceuticals Incannex Healthcare RAPT Therapeutics RenovoRx ProMIS Neurosciences LianBio NextCure DURECT KALA BIO Surrozen (NASDAQ:SRZN) and Biofrontera (NASDAQ:BFRI) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, community ranking, media sentiment, valuation, profitability and analyst recommendations. Do analysts rate SRZN or BFRI? Biofrontera has a consensus target price of $7.00, suggesting a potential upside of 614.29%. Given Biofrontera's stronger consensus rating and higher possible upside, analysts clearly believe Biofrontera is more favorable than Surrozen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Surrozen 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Biofrontera 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community prefer SRZN or BFRI? Biofrontera received 5 more outperform votes than Surrozen when rated by MarketBeat users. Likewise, 66.67% of users gave Biofrontera an outperform vote while only 16.67% of users gave Surrozen an outperform vote. CompanyUnderperformOutperformSurrozenOutperform Votes316.67%Underperform Votes1583.33% BiofronteraOutperform Votes866.67% Underperform Votes433.33% Do insiders and institutionals hold more shares of SRZN or BFRI? 66.6% of Surrozen shares are held by institutional investors. Comparatively, 10.1% of Biofrontera shares are held by institutional investors. 43.5% of Surrozen shares are held by insiders. Comparatively, 0.2% of Biofrontera shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media prefer SRZN or BFRI? In the previous week, Surrozen's average media sentiment score of 0.00 equaled Biofrontera'saverage media sentiment score. Company Overall Sentiment Surrozen Neutral Biofrontera Neutral Is SRZN or BFRI more profitable? Surrozen has a net margin of 0.00% compared to Biofrontera's net margin of -36.31%. Surrozen's return on equity of -120.51% beat Biofrontera's return on equity.Company Net Margins Return on Equity Return on Assets SurrozenN/A -120.51% -54.68% Biofrontera -36.31%-565.73%-96.64% Which has preferable valuation & earnings, SRZN or BFRI? Biofrontera has higher revenue and earnings than Surrozen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSurrozen$10M3.43-$43.04MN/AN/ABiofrontera$35.36M0.21-$20.13M-$2.26-0.43 Which has more risk and volatility, SRZN or BFRI? Surrozen has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Comparatively, Biofrontera has a beta of 0.38, meaning that its stock price is 62% less volatile than the S&P 500. SummarySurrozen and Biofrontera tied by winning 7 of the 14 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get Biofrontera News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BFRI vs. The Competition Export to ExcelMetricBiofronteraPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.59M$6.57B$5.12B$9.07BDividend YieldN/A2.98%4.91%4.22%P/E Ratio-0.4310.5991.3417.19Price / Sales0.21195.381,116.59116.80Price / CashN/A57.1642.6437.86Price / Book0.315.104.794.78Net Income-$20.13M$151.51M$120.07M$225.60M7 Day Performance-7.55%-2.15%-1.89%-1.24%1 Month Performance29.12%-3.14%11.45%3.36%1 Year Performance-69.66%11.50%30.61%16.58% Biofrontera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BFRIBiofrontera1.4519 of 5 stars$0.98-3.9%$7.00+614.3%-71.2%$7.59M$35.36M-0.4370Gap DownSRZNSurrozen1.086 of 5 stars$10.09+2.4%N/A+32.3%$32.79M$10M0.0042VRCAVerrica Pharmaceuticals4.6557 of 5 stars$0.72-5.7%$9.50+1,224.2%-87.7%$32.71M$5.12M-0.4040Analyst ForecastNews CoverageIXHLIncannex HealthcareN/A$1.83-1.6%N/A-54.1%$32.29M$86,000.00-1.343RAPTRAPT Therapeutics4.5209 of 5 stars$0.91-0.3%$9.50+947.1%-96.1%$31.72M$1.53M-0.3380RNXTRenovoRx1.2324 of 5 stars$1.27-0.8%$6.50+411.8%+76.1%$30.48MN/A-2.256Positive NewsGap UpPMNProMIS Neurosciences1.0717 of 5 stars$0.91-2.7%N/A-20.2%$29.58M$10,000.00-9.306Positive NewsLIANLianBioN/A$0.27flat$3.50+1,194.4%-94.2%$29.22MN/A-0.33110NXTCNextCure4.2168 of 5 stars$1.02-5.6%$4.00+292.2%-14.9%$28.57MN/A-0.5290Positive NewsDRRXDURECT2.6267 of 5 stars$0.92+22.0%$5.00+446.3%+89.2%$28.41M$8.59M-1.3980Analyst ForecastNews CoverageHigh Trading VolumeKALAKALA BIO3.8466 of 5 stars$6.10-1.3%$15.00+145.9%-13.3%$28.12M$3.89M-0.5030Gap Down Related Companies and Tools Related Companies SRZN Competitors VRCA Competitors IXHL Competitors RAPT Competitors RNXT Competitors PMN Competitors LIAN Competitors NXTC Competitors DRRX Competitors KALA Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BFRI) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biofrontera Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biofrontera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
